Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Konstantinos Kamnitsas

Professor Konstantinos Kamnitsas

Konstantinos Kamnitsas


Associate Professor of Engineering Science

Konstantinos Kamnitsas is Associate Professor of Engineering Science (Medical Imaging) at the Department of Engineering Science and the Institute of Biomedical Engineering (IBME) of the University of Oxford, and Non-Tutorial Fellow at Wolfson College.

He is co-director of the EPSRC CDT in Healthcare Data Science (2024-). His research focuses on Machine-Learning (ML) and primarily deep neural networks for medical image analysis. His work has two main goals:

  • Develop reliable, transparent and accountable AI models for safe use in healthcare.
  • Empower radiologists, clinicians and researchers with intelligent ML-based tools to better address their research questions and needs of clinical workflows.

Konstantinos completed his PhD at Imperial College London in 2019, where he pioneered development of 3-dimensional neural networks for analysing volumetric medical data, such as MRI and CT, and methods for improving generalization to heterogeneous data. He previously obtained an MSc in Computing Science from Imperial College, and Diploma in Electrical and Computer Engineering from Aristotle University of Thessaloniki, Greece.

He has also conducted research in industry, such as at Microsoft Research and Kheiron Medical Technologies. He became Lecturer at the University of Birmingham in 2021, before moving to Oxford in 2022. His work won various awards, among which international competitions for segmentation of cancer and stroke lesions.